ELEVANCE HEALTH, INC. Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
ELEVANCE HEALTH, INC. (ELV) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $4.92 billion for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-29.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2015-04-29
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2015-03-31 was $4.92B, a 102.52% increase year-over-year.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-12-31 was $4.66B.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-09-30 was -$578.60M, a 119.65% decline year-over-year.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-06-30 was -$814.80M.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2014 was $5.69B, a 54.20% increase from fiscal 2013.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2013 was $3.69B, a 100.94% increase from fiscal 2012.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $1.84B, a 57.61% decline from fiscal 2011.
- ELEVANCE HEALTH, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2011 was $4.33B, a 2818.32% increase from fiscal 2010.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 0 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2015-03-31 | $4.92B 10-Q · filed 2015-04-29 | $9.57B derived: sum of 2 quarters · filed 2015-04-29 | $9.00B derived: sum of 3 quarters · filed 2015-04-29 | $8.18B derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2014-12-31 | $4.66B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $4.08B derived: sum of 2 quarters · filed 2015-02-24 | $3.26B derived: sum of 3 quarters · filed 2015-02-24 | $5.69B 10-K · filed 2015-02-24 | ||
| 2014-09-30 | -$578.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$1.39B derived: sum of 2 quarters · filed 2014-10-29 | $1.03B 10-Q · filed 2014-10-29 | $559.30M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2014-06-30 | -$814.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $1.61B 10-Q · filed 2014-07-30 | $1.14B derived: sum of 3 quarters · filed 2015-04-29 | $4.08B derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2014-03-31 | $2.43B 10-Q · filed 2015-04-29 | $1.95B derived: sum of 2 quarters · filed 2015-04-29 | $4.90B derived: sum of 3 quarters · filed 2015-04-29 | $4.62B derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-12-31 | -$475.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $2.47B derived: sum of 2 quarters · filed 2015-02-24 | $2.19B derived: sum of 3 quarters · filed 2015-02-24 | $3.69B 10-K · filed 2015-02-24 | ||
| 2013-10-10 | $4.09B 10-Q · filed 2013-10-23 | |||||
| 2013-09-30 | $2.95B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $2.67B derived: sum of 2 quarters · filed 2014-10-29 | $4.17B 10-Q · filed 2014-10-29 | $3.50B derived: sum of 4 quarters · filed 2014-10-29 | ||
| 2013-07-11 | $1.16B 10-Q · filed 2013-07-24 | |||||
| 2013-06-30 | -$275.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $1.22B 10-Q · filed 2013-07-24 | $553.30M derived: sum of 3 quarters · filed 2014-07-30 | -$102.00M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-04-11 | $1.47B 10-Q · filed 2013-04-24 | |||||
| 2013-03-31 | $1.50B 10-Q · filed 2014-04-30 | $828.60M derived: sum of 2 quarters · filed 2014-04-30 | $173.30M derived: sum of 3 quarters · filed 2014-04-30 | -$320.40M derived: sum of 4 quarters · filed 2014-04-30 | ||
| 2013-02-08 | $1.77B 10-K · filed 2013-02-22 | |||||
| 2012-12-31 | -$668.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$1.32B derived: sum of 2 quarters · filed 2014-02-20 | -$1.82B derived: sum of 3 quarters · filed 2014-02-20 | $1.84B 10-K · filed 2014-02-20 | ||
| 2012-10-31 | $1.87B 10-Q · filed 2012-11-07 | |||||
| 2012-09-30 | -$655.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$1.15B derived: sum of 2 quarters · filed 2013-10-23 | $2.50B 10-Q · filed 2013-10-23 | $1.82B derived: sum of 4 quarters · filed 2013-10-23 | ||
| 2012-07-12 | $3.16B 10-Q · filed 2012-07-25 | |||||
| 2012-06-30 | -$493.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-24 | $3.16B 10-Q · filed 2013-07-24 | $2.47B derived: sum of 3 quarters · filed 2013-07-24 | $6.83B derived: sum of 4 quarters · filed 2013-07-24 | ||
| 2012-04-12 | $3.58B 10-Q · filed 2012-04-25 | |||||
| 2012-03-31 | $3.65B 10-Q · filed 2013-04-24 | $2.97B derived: sum of 2 quarters · filed 2013-04-24 | $7.32B derived: sum of 3 quarters · filed 2013-04-24 | $7.11B derived: sum of 4 quarters · filed 2013-04-24 | ||
| 2012-02-09 | $4.00B 10-K · filed 2012-02-22 | |||||
| 2011-12-31 | -$685.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $3.67B derived: sum of 2 quarters · filed 2013-02-22 | $3.45B derived: sum of 3 quarters · filed 2013-02-22 | $4.33B 10-K · filed 2013-02-22 | ||
| 2011-09-30 | $4.35B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $4.14B derived: sum of 2 quarters · filed 2012-11-07 | $5.02B 10-Q · filed 2012-11-07 | |||
| 2011-06-30 | -$214.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $667.20M 10-Q · filed 2012-07-25 | ||||
| 2011-03-31 | $882.00M 10-Q · filed 2012-04-25 | |||||
| 2010-12-31 | $148.50M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |